Table 2.
Comparison of Percentage of Patients Accrued to Specific Cancer Trials with Percentage of Cancer Cases in Maryland by Sex and Cancer Site, 1999 to 2002
| Male |
Female |
|||||||
|---|---|---|---|---|---|---|---|---|
| Cancer Subtype | No. of Annual Cases |
No. of Trial Patients |
% - MD Cancer Burden* |
% - Cancer Trial Patients** |
No. of Annual Cases |
No. of Trial Patients |
% - MD Cancer Burden* |
% - Cancer Trial Patients** |
| Non sex-specific tumors | ||||||||
| Colorectal | 5253 | 68 | 10.5 | 7.4 | 5283 | 64 | 11.2 | 4.8 |
| Lung | 7371 | 38 | 14.8 | 4.2 | 6208 | 38 | 13.2 | 2.9 |
| Lymphoma | 2047 | 120 | 4.1 | 13.1 | 1822 | 55 | 3.9 | 4.2 |
| Leukemia | 994 | 202 | 2.0 | 22.1 | 804 | 131 | 1.7 | 9.9 |
| Sex-specific tumors | ||||||||
| Male Reproductive System Neoplasm |
16086 | 197 | 32.3 | 21.6 | ~ | ~ | ~ | ~ |
| Female Breast | ~ | ~ | ~ | ~ | 14620 | 712 | 31.1 | 53.7 |
| Female Reproductive System Neoplasm |
~ | ~ | ~ | ~ | 1179 | 163 | 2.5 | 12.3 |
*
% MD Cancer Burden is the site-specific number of cancer cases/total number of cancer cases*100; data are from the Maryland Cancer Registry
**
% Cancer Trial Patients is the site-specific number of clinical treatment trial patients/total number of clinical treatment trial patients; data are from CTEP